Complementary Alternative Cardiovascular Medicine

134 Alternative Cardiovascular Medicine
23. Bishop SR. What do we really know about mindfulness-based stress reduction?
Psychosom Med 2002;64:71–84.
24. Kabat-Zinn J. Meditation. In: Holland JC, ed. Psycho-oncology. Oxford University
Press, New York, 1998, pp.767–779.
25. Brose T. A psychophysiological study. Main Curr Mod Thought 1946;4:77–84.
26. Wallace RK. Physiological effects of transcendental meditation. Science
1970;167:1251–1254.
27. Wallace RK, Benson H, Wilson AF. A wakeful hypometabolic physiologic state.
Am J Physiol 1971;221:795–799.
28. Wallace RK, Benson H. The physiology of meditation. Sci Amer 1972;262:84–90.
29. Wolkove N, Kreisman H, Darragh D, Cohen C, Frank H. Effect of transcendental
meditation on breathing and respiratory control. J Appl Physiol 1984;56:607–612.
30. Farrow JT, Hebert R. Breath suspension during the transcendental meditation technique.
Psychosom Med 1982;44:133–153.
31. Badawi K, Wallace RK, Orme-Johnson D, Rouzere AM. Electrophysiological characteristics
of respiratory suspension periods occurring during the practice of the
Transcendental Meditation program. Psychosom Med 1984;46:267–276.
32. Travis F, Wallace RK. Autonomic patterns during respiratory suspensions: possible
markers of transcendental consciousness. Psychophysiology 1997;34:39–46.
33. Jevning R, Wilson AF, Davidson MJ. Adrenocortical activity during meditation.
Horm Behav 1978;10:54–60.
34. MacLean CRK, Walton KG, Wenneberg SR, et al. Effects of the Transcendental
Meditation program on adaptive mechanisms: changes in hormone levels and
responses to stress after 4 months of practice. Psychoneuroendocrinology
1997;22:277–295.
35. Werner OR, Wallace RK, Charles B, Janssen G, Stryker T, Chalmers RA. Long term
endocrinologic changes in subjects practicing the Transcendental Meditation and
TM-Sidhi program. Psychosom Med 1986;48:59–66.
36. Michaels RR, Huber MJ, McCann DS. Evaluation of transcendental meditation as
a method of reducing stress. Science 1976;192:1242–1244.
37. Infante JR, Torres-Avisbal M, Pinel P, et al. Catecholamine levels in practitioners
of the transcendental meditation technique. Phys Behav 2001;72:141–146.
38. Wallace RK, Simon B, Guich S, et al. Rise in urinary 5-hydroxyindoleaceatic acid
(5-HIAA) associated with practice of the transcendental meditation program. Soc
Neurosci Abs 1980;6:725.
39. Dillbeck MC, Orme-Johnson DW. Physiological differences between transcendental
meditation and rest. Am Psychol 1987;42:879–881.
40. Goleman D, Schwartz G. Meditation as an intervention in stress-reactivity. J Consult
Clin Psychol 1976;44:456–466.
41. Michaels RR, Pano J, McCann DS, Vander AJ. Renin, cortisol and aldosterone
during transcendental meditation. Psychosom Med 1979;41:50–54.
42. Wallace RK, Silver J, Mills PJ, Dillbeck MC, Wagoner DE. Systolic blood pressure
and long term practice of the Transcendental Meditation and TM-Sidhi programs:
effects of TM on systolic blood pressure. Psychosom Med 1983;45:451–456.
43. Barnes VA, Treiber FA, Turner JR, Davis H. Acute effects of transcendental meditation
on hemodynamic functioning in middle-aged adults. Psychosom Med
1999;61:525–531.
44. Wenneberg SR, Schneider RH, Walton KG, et al. A controlled study of the effects
of the transcendental meditation program on cardiovascular reactivity and ambulatory
blood pressure. Int J Neurosci 1997;89:15–28.